PolyTherics’ growth spurs move to larger premises
Since its establishment in 2002, PolyTherics has grown from an initial staff of one to the current multi-national team of 30. This growth is being driven by the progress of its own biobetter programmes toward development and the increasing number of agreements that PolyTherics has in place to adapt and improve drugs for third parties.
Dr Keith Powell, CEO of PolyTherics, commented that: “This expansion marks an important step in the growth of the Company. Having secured deals with a number of prestigious partners, the expansion will allow us to further develop our partnerships and ensure Polytherics is well placed for future growth. PolyTherics has always been a London-based company and we wish to maintain the advantages of being easily accessible to world-wide customers and collaborators. We are delighted that LBIC was able to accommodate our expansion and that we can continue to grow our business in London with their support.”
PolyTherics has been located in The London BioScience Innovation Centre (“LBIC”), which is owned and managed by the adjacent Royal Veterinary College, since 2006. The RVC has now refurbished part of another building that it owns so that LBIC can provide additional laboratory and office space to companies as they grow beyond the incubator space. PolyTherics is the first such company and is taking the whole of the first floor of this building.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.